HopeStage
Back to overview

Depression studies

Topics
More filters

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 1,657-1,668 of 7,264
Drug study icon
CompletedNCT05066672

NV-5138 for treatment-resistant depression

What is this study about?

This study evaluated the safety and effectiveness of NV-5138 for people with depression.

This study has finished and is no longer accepting participants.

In Bellevue
DepressionMedication studyAges 18–70
Countries
United States
Sponsor
Navitor Pharmaceuticals, Inc.
Drug study icon
Active Not RecruitingNCT06731621

Psilocybin for Treatment-Resistant Depression in Autism

Official study title

Psilocybin for Treatment-Resistant Depression in Autism: a Pilot Trial With Pre-Post Brain and Cognitive Measurement to Understand Mechanism

This study is no longer accepting new participants.

In Toronto
DepressionMedication studyAges 18–65
Countries
Canada
Sponsor
Centre for Addiction and Mental Health (Hospital / academic medical center)
Behavioral study icon
CompletedACTRN12613000139774

Comparison of two different versions of Cognitive Bias Modification (CBM) plus Internet Cognitive Behavioural Therapy (iCBT) for depression

Official study title

A randomised controlled trial comparing Internet based cognitive behavioural therapy for major depressive disorder plus a cognitive bias modification intervention (OxIGen) version A vs. Internet based cognitive behavioural therapy for major depressive disorder plus a cognitive bias modification intervention (OxIGen) version B on symptoms of depression and negative interpretation bias.

This study has finished and is no longer accepting participants.

In Australia
DepressionInterventional studyAges 18–65
Countries
Australia
Sponsor
St Vincent's Hospital
Drug study icon
CompletedACTRN12619000575134

Study of PRAX-114 to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy in people with Major Depressive Disorder

Official study title

A Phase 2 Clinical Trial of PRAX-114 to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy in Participants with Major Depressive Disorder

This study has finished and is no longer accepting participants.

In Australia
DepressionInterventional studyAges 18–65
Countries
Australia
Sponsor
Praxis Precision Medicines Australia, Pty Ltd
Other study type icon
TerminatedACTRN12624000864527

Development of a website for family/friends of adults with depression

Official study title

Evaluating the acceptability, usability, usefulness of, and engagement with Depression Assist, a psychoeducation website for close family/friends of adults with major depressive disorder

This study ended early.

In Australia
DepressionInterventional studyAges 18+
Countries
Australia
Sponsor
Deakin University
Drug study icon
CompletedACTRN12613001300763

Nutraceuticals as Adjunctive Treatments in Major Depressive Disorder (NAT-D): A study

Official study title

The Efficacy of S-Adenosyl Methionine (SAMe) and a Combination Nutraceutical as Adjunctive Treatments in Major Depressive Disorder: A Double-Blind, Randomised, Placebo-Controlled Trial

This study has finished and is no longer accepting participants.

Multiple locations, including Richmond
DepressionInterventional studyAges 18–75
Countries
Australia
Sponsor
University of Melbourne

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.